Literature DB >> 16261465

Propofol attenuates oxidant-induced acute lung injury in an isolated perfused rabbit-lung model.

Masato Yumoto1, Osamu Nishida, Fujio Nakamura, Hirotada Katsuya.   

Abstract

PURPOSE: Reactive oxygen species have been strongly implicated in the pathogenesis of acute lung injury (ALI). Some animal studies suggest that free radical scavengers inhibit the onset of oxidant-induced ALI. Propofol (2,6-diisopropylphenol) is chemically similar to phenol-based free radical scavengers such as the endogenous antioxidant vitamin E. Both in vivo and in vitro studies have suggested that propofol has antioxidant potential. We hypothesized that propofol may attenuate ALI by acting as a free-radical scavenger.
METHODS: We investigated the effects of propofol on oxidant-induced ALI induced by purine and xanthine oxidase (XO), in isolated perfused rabbit lung, in two series of experiments. In series 1, we examined the relationship between the severity of ALI and the presence of hydrogen peroxide (H2O2). In series 2, we evaluated the effects of propofol on attenuating ALI and the dose dependence of these effects. The lungs were perfused for 90 min, and we evaluated the effects on the severity of ALI by monitoring the pulmonary capillary filtration coefficient (Kfc), pulmonary arterial pressure (Ppa), and the pulmonary capillary hydrostatic pressure (Ppc).
RESULTS: In series 1, treatment with catalase (an H2O2 scavenger) prior to the addition of purine and XO resulted in complete prevention of ALI, suggesting that H2O2 may be involved closely in the pathogenesis of ALI. In series 2, pretreatment with propofol at concentrations in excess of 0.5 mM significantly inhibited the increases in the Kfc values, and that in excess of 0.75 mM significantly inhibited the increase in the Ppa values.
CONCLUSION: Propofol attenuates oxidant-induced ALI in an isolated perfused rabbit lung model, probably due to its antioxidant action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261465     DOI: 10.1007/s00540-005-0338-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  20 in total

Review 1.  Pharmacologic modulation of lung injury.

Authors:  S I Said; H D Foda
Journal:  Am Rev Respir Dis       Date:  1989-06

2.  Validation of double vascular occlusion method for Pc,i in lung and skeletal muscle.

Authors:  M I Townsley; R J Korthuis; B Rippe; J C Parker; A E Taylor
Journal:  J Appl Physiol (1985)       Date:  1986-07

3.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

Review 4.  Xanthine oxidase: biochemistry, distribution and physiology.

Authors:  D A Parks; D N Granger
Journal:  Acta Physiol Scand Suppl       Date:  1986

5.  Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery.

Authors:  M M Sayin; O Ozatamer; R Taşöz; K Kilinç; N Unal
Journal:  Br J Anaesth       Date:  2002-08       Impact factor: 9.166

6.  Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis.

Authors:  U Suchner; D P Katz; P Fürst; K Beck; T W Felbinger; U Senftleben; M Thiel; A E Goetz; K Peter
Journal:  Crit Care Med       Date:  2001-08       Impact factor: 7.598

7.  Antioxidant protection of propofol and its recycling in erythrocyte membranes.

Authors:  Masahiko Tsuchiya; Akira Asada; Emiko Kasahara; Eisuke F Sato; Mitsuo Shindo; Masayasu Inoue
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

8.  Intralipid alterations in pulmonary prostaglandin metabolism and gas exchange.

Authors:  J R Hageman; K McCulloch; P Gora; E K Olsen; L Pachman; C E Hunt
Journal:  Crit Care Med       Date:  1983-10       Impact factor: 7.598

9.  The antioxidant potential of propofol (2,6-diisopropylphenol).

Authors:  P G Murphy; D S Myers; M J Davies; N R Webster; J G Jones
Journal:  Br J Anaesth       Date:  1992-06       Impact factor: 9.166

10.  The widely used anesthetic agent propofol can replace alpha-tocopherol as an antioxidant.

Authors:  L Aarts; R van der Hee; I Dekker; J de Jong; H Langemeijer; A Bast
Journal:  FEBS Lett       Date:  1995-01-02       Impact factor: 4.124

View more
  7 in total

1.  Propofol Prevents Oxidative Stress by Decreasing the Ischemic Accumulation of Succinate in Focal Cerebral Ischemia-Reperfusion Injury.

Authors:  Wei Yu; Dapeng Gao; Wen Jin; Siliang Liu; Sihua Qi
Journal:  Neurochem Res       Date:  2017-11-22       Impact factor: 3.996

2.  Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin.

Authors:  H Shao; J Li; Y Zhou; Z Ge; J Fan; Z Shao; Y Zeng
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 3.  Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets.

Authors:  Ting Wang; Christine Gross; Ankit A Desai; Evgeny Zemskov; Xiaomin Wu; Alexander N Garcia; Jeffrey R Jacobson; Jason X-J Yuan; Joe G N Garcia; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-15       Impact factor: 5.464

4.  Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury.

Authors:  Chou-Chin Lan; Chung-Kan Peng; Shih-En Tang; Kun-Lun Huang; Chin-Pyng Wu
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

5.  Hypoxia mediated pulmonary edema: potential influence of oxidative stress, sympathetic activation and cerebral blood flow.

Authors:  Shadi Khademi; Melinda A Frye; Kimberly M Jeckel; Thies Schroeder; Eric Monnet; Dave C Irwin; Patricia A Cole; Christopher Bell; Benjamin F Miller; Karyn L Hamilton
Journal:  BMC Physiol       Date:  2015-10-09

6.  Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-κB Activation in Ischemia-Reperfusion Lung Injury.

Authors:  Chou-Chin Lan; Chung-Kan Peng; Shih-En Tang; Shu-Yu Wu; Kun-Lun Huang; Chin-Pyng Wu
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

7.  Surfactant Attenuates Air Embolism-Induced Lung Injury by Suppressing NKCC1 Expression and NF-κB Activation.

Authors:  Chou-Chin Lan; Yao-Kuang Wu; Chung-Kan Peng; Kun-Lun Huang; Chin-Pyng Wu
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.